- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03477318
Accuracy of Endoscopists in Predicting Polyp Pathology
June 12, 2019 updated by: TriHealth Inc.
The study purpose is to assess the accuracy of experienced endoscopists at a community hospital in predicting histological types of polyps resected at colonoscopy using white light.
Patients 50 years or older undergoing first-time screening colonoscopy will be included in this observational study.
Study Overview
Status
Completed
Conditions
Detailed Description
The study purpose is to assess the accuracy of experienced endoscopists at a community hospital in predicting histological types of polyps resected at colonoscopy using white light.
The study will be conducted at Good Samaritan Hospital and TriHealth Surgery Center West.
Study participants include patients 50 years or older undergoing first-time screening colonoscopy.
This is an observational study and does not involve any patient interventions.
After completing the colonoscopy, the endoscopist will document their prediction of the polyp type.
The polyp type predicted by the endoscopist will be compared to the polyp type documented in the pathology report to determine accuracy.
It is estimated that study enrollment will take 6 months.
Study Type
Observational
Enrollment (Actual)
159
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45220
- Good Samaritan Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients 50 years or older undergoing first-time screening colonoscopy
Description
Inclusion Criteria:
- Males and females
Exclusion Criteria:
- first degree relative diagnosed with colorectal carcinoma at age 59 or under
- New onset of iron deficiency anemia (within past 3 months)
- Abnormal imaging of colon within past 3 months
- Pregnant women
- Inadequate visualization reported by endoscopist
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Patients undergoing screening colonoscopy
Patients undergoing first-time colonoscopy using white light with at least 1 polyp resected.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Polyp prediction accuracy
Time Frame: up to 5 days
|
Accuracy of predicting polyp type
|
up to 5 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 20, 2018
Primary Completion (Actual)
November 7, 2018
Study Completion (Actual)
November 7, 2018
Study Registration Dates
First Submitted
March 20, 2018
First Submitted That Met QC Criteria
March 20, 2018
First Posted (Actual)
March 26, 2018
Study Record Updates
Last Update Posted (Actual)
June 14, 2019
Last Update Submitted That Met QC Criteria
June 12, 2019
Last Verified
May 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17-075
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Resected Polyp
-
University of ManitobaActive, not recruitingPolyps | Colonic Polyp | Polyp of Colon | Colo-rectal Cancer | Colon Polyp | Rectal Polyp | Polyp RectalCanada
-
Georgetown UniversityRecruitingResected Pancreatic AdenocarcinomaUnited States
-
South Tyneside and Sunderland NHS Foundation TrustMedtronic; Newcastle University; North Wales Organisation for Randomised Trials...CompletedColonic Polyp | Colorectal Adenoma | Colorectal Polyp | Colorectal SSA | Colorectal Adenomatous Polyp | Sessile Serrated Adenoma | Sessile Colonic PolypUnited Kingdom
-
Vejle HospitalNot yet recruitingColorectal Cancer | Colonic Polyp | Colorectal Polyp | Shared Decision Making | Decision Aids | Rectal Polyp
-
M.D. Anderson Cancer CenterSuspended
-
Sidney Kimmel Comprehensive Cancer Center at Johns...CompletedBreast Cancer | Resected Breast CancerUnited States
-
Hospital Clinic of BarcelonaInstituto de Salud Carlos IIICompletedArtificial Intelligence | Colonoscopy | Colorectal Polyp | Histology | Hyperplastic Polyp | Computer-aided Diagnosis | Adenoma Colon PolypSpain
-
Soon Chun Hyang UniversityCompletedColonoscopy | Adenomatous Polyp | Hyperplastic Polyp | Diminutive Colon PolypKorea, Republic of
-
University College, LondonNot yet recruitingPolyps | Colon Polyp | Adenoma Colon | Colorectal Polyp | Polyps of ColonUnited Kingdom
-
Asan Medical CenterCompletedResected Advanced Gastric CancerKorea, Republic of